Radiation Medicine Program, Princess Margaret Cancer Center, University Health Network, Toronto, ON, Canada .
J Appl Clin Med Phys. 2013 May 6;14(3):4053. doi: 10.1120/jacmp.v14i3.4053.
This study investigates the dosimetry and radiobiological model variation when a second photon arc was added to prostate volumetric-modulated arc therapy (VMAT) using the single-arc technique. Dosimetry and radiobiological model comparison between the single-arc and double-arc prostate VMAT plans were performed on five patients with prostate volumes ranging from 29-68.1 cm3. The prescription dose was 78 Gy/39 fractions and the photon beam energy was 6 MV. Dose-volume histogram, mean and maximum dose of targets (planning and clinical target volume) and normal tissues (rectum, bladder and femoral heads), dose-volume criteria in the treatment plan (D99% of PTV; D30%, D50%, V17Gy and V35Gy of rectum and bladder; D5% of femoral heads), and dose profiles along the vertical and horizontal axis crossing the isocenter were determined using the single-arc and double-arc VMAT technique. For comparison, the monitor unit based on the RapidArc delivery method, prostate tumor control probability (TCP), and rectal normal tissue complication probability (NTCP) based on the Lyman-Burman-Kutcher algorithm were calculated. It was found that though the double-arc technique required almost double the treatment time than the single-arc, the double-arc plan provided a better rectal and bladder dose-volume criteria by shifting the delivered dose in the patient from the anterior-posterior direction to the lateral. As the femoral head was less radiosensitive than the rectum and bladder, the double-arc technique resulted in a prostate VMAT plan with better prostate coverage and rectal dose-volume criteria compared to the single-arc. The prostate TCP of the double-arc plan was found slightly increased (0.16%) compared to the single-arc. Therefore, when the rectal dose-volume criteria are very difficult to achieve in a single-arc prostate VMAT plan, it is worthwhile to consider the double-arc technique.
本研究旨在探讨在使用单弧技术的前列腺容积调强弧形治疗(VMAT)中增加第二个光子弧时剂量学和放射生物学模型的变化。对 5 例前列腺体积为 29-68.1 cm3 的患者进行了单弧和双弧前列腺 VMAT 计划的剂量学和放射生物学模型比较。处方剂量为 78 Gy/39 次,光子束能量为 6 MV。使用单弧和双弧 VMAT 技术,确定了靶区(计划靶区和临床靶区)和正常组织(直肠、膀胱和股骨头)的剂量-体积直方图、平均剂量和最大剂量、治疗计划中的剂量-体积标准(PTV 的 D99%;直肠和膀胱的 D30%、D50%、V17Gy 和 V35Gy;股骨头的 D5%)以及穿过等中心的垂直和水平轴的剂量分布。为了比较,根据 RapidArc 治疗方法计算了基于单位的 Monitor Unit、基于 Lyman-Burman-Kutcher 算法的前列腺肿瘤控制概率(TCP)和直肠正常组织并发症概率(NTCP)。结果发现,虽然双弧技术比单弧技术所需的治疗时间几乎增加了一倍,但通过将患者的剂量从前-后方向转移到侧向,双弧计划提供了更好的直肠和膀胱剂量-体积标准。由于股骨头比直肠和膀胱的放射敏感性低,与单弧相比,双弧技术可使前列腺覆盖率和直肠剂量-体积标准更好的前列腺 VMAT 计划。与单弧相比,双弧计划的前列腺 TCP 略有增加(0.16%)。因此,当单弧前列腺 VMAT 计划中直肠剂量-体积标准非常难以达到时,值得考虑双弧技术。